poloxalene has been researched along with folic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cui, Y; Li, LB; Ling, P; Xu, W | 1 |
Feng, L; Li, M; Liu, F; Liu, Y; Zhang, L; Zhang, N | 1 |
Fu, S; Han, L; Lin, J; Liu, C; Lu, X; Yang, C; Zhao, C | 1 |
3 other study(ies) available for poloxalene and folic acid
Article | Year |
---|---|
Preparation and evaluation of folate-modified cationic pluronic micelles for poorly soluble anticancer drug.
Topics: Animals; Cations; Chemistry, Pharmaceutical; Drug Evaluation, Preclinical; Folic Acid; HeLa Cells; Humans; Injections, Intravenous; Micelles; Poloxalene; Poloxamer; Polyethyleneimine; Rats; Solubility; Tissue Distribution | 2012 |
Polymeric complex micelles with double drug-loading strategies for folate-mediated paclitaxel delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; MCF-7 Cells; Melanoma, Experimental; Mice; Micelles; Microscopy, Electron, Transmission; Models, Chemical; Molecular Structure; Paclitaxel; Poloxalene; Polymers; Treatment Outcome | 2015 |
Redox-responsive F127-folate/F127-disulfide bond-d-α-tocopheryl polyethylene glycol 1000 succinate/P123 mixed micelles loaded with paclitaxel for the reversal of multidrug resistance in tumors.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Disulfides; Drug Liberation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endocytosis; Folic Acid; Humans; Inhibitory Concentration 50; MCF-7 Cells; Micelles; Mitochondria; Neoplasms; Oxidation-Reduction; Paclitaxel; Poloxalene; Poloxamer; Reactive Oxygen Species; Vitamin E | 2018 |